Agenovir

Antios Therapeutics

This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.

Excision Biotherapeutics

This biotechnology company develops CRISPR-based gene editing therapies designed to cure chronic viral infectious diseases for patients.

Kovina Therapeutics

The company develops antiviral therapies to treat cancers and pre-malignant infections caused by Human Papillomavirus for patients with existing infections.

Eradivir

This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.

Akribion Therapeutics

The company develops RNA-guided nuclease technology for programmable cell depletion to treat cancer and autoimmune diseases for healthcare providers and patients.

ReViral

This company develops antiviral therapeutics for respiratory syncytial virus to treat pediatric, immunocompromised and elderly patients.

Halo Therapeutics

This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.